biologic medicines
搜索文档
Atle Fund Management AB Decreases Holdings in Amgen Inc. $AMGN
Defense World· 2026-02-01 16:04
Atle Fund Management AB decreased its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 42.2% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 13,806 shares of the medical research company’s stock after selling 10,088 shares during the period. Amgen makes up about 1.5% of Atle Fund Management AB’s holdings, making the stock its 26th biggest holding. Atle Fund Management AB’s holdings in Amgen were worth $3,896,000 at the end of the most recent ...